Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Theriva Biologics Q3 EPS $(0.33) Beats $(0.39) Estimate

Theriva Biologics (AMEX:TOVX) reported quarterly losses of $(0.33) per share which beat the analyst consensus estimate of $(0.39) by 15.38 percent. This is a 65 percent decrease over losses of $(0.20) per share from the
byBenzinga Newsdesk
November 10, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Theriva Biologics (AMEX:TOVX) reported quarterly losses of $(0.33) per share which beat the analyst consensus estimate of $(0.39) by 15.38 percent. This is a 65 percent decrease over losses of $(0.20) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts